HCA
CLB icon

Harbor Capital Advisors’s Core Laboratories CLB Stock Holding History

Harbor Capital Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Buy
+509
New +$9.11K ﹤0.01% 1003

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbor Capital Advisors's CLB Position: Q1 2026 in Review

Harbor Capital Advisors opened a new position in Core Laboratories (CLB) in Q1 2026: 509 shares worth $9K. The stake represents ﹤0.01% of the portfolio and ranks #1003 among its holdings.

190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Harbor Capital Advisors held 509 shares of Core Laboratories worth $9K as of Q1 2026.
  • Core Laboratories was a new Harbor Capital Advisors position in Q1 2026.
  • Core Laboratories made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q1 2026, its #1003 holding.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.